Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histological”

43,811 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43,811 results

Early research (Phase 1)Looking for participantsNCT06723236
What this trial is testing

MGC028 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNSCLC AdenocarcinomaCholangiocarcinoma+2 more
MacroGenics 124
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT03548467
What this trial is testing

Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
Nykode Therapeutics ASA 41
Early research (Phase 1)UnknownNCT05552807
What this trial is testing

SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Carcinoma
Sinocelltech Ltd. 120
Early research (Phase 1)Study completedNCT01957007
What this trial is testing

Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC

Who this might be right for
Solid Tumors
OncoMed Pharmaceuticals, Inc. 34
Early research (Phase 1)Study completedNCT01241292
What this trial is testing

Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 7
Testing effectiveness (Phase 2)Looking for participantsNCT03624244
What this trial is testing

Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)

Who this might be right for
Low Grade Endometrial Stromal Sarcoma
Centre Leon Berard 40
Not applicableUnknownNCT06355700
What this trial is testing

Hepatocellular Carcinoma Liver Organoids

Who this might be right for
Hepatocellular Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 10
Not applicableNot Yet RecruitingNCT06787807
What this trial is testing

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Who this might be right for
ObesityColon CancerThyroid Cancer+14 more
Universidade Federal de Pernambuco 103
Testing effectiveness (Phase 2)Study completedNCT01840007
What this trial is testing

Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma

Who this might be right for
Metastatic Melanoma (Stage IIIC Non-résécable or no Surgically Curable or Stage IV With Classification AJCC)
Centre Hospitalier Universitaire de Nice 20
Not applicableNot Yet RecruitingNCT05004792
What this trial is testing

Dermoscopy Augmented Histology Trial, a Randomized Controlled Trial

Who this might be right for
MelanomaPigmented Lesions
Herlev Hospital 258
Early research (Phase 1)Study completedNCT00005807
What this trial is testing

Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer

Who this might be right for
Breast CancerOvarian CancerUnspecified Adult Solid Tumor, Protocol Specific
Albert Einstein College of Medicine 40
Early research (Phase 1)Study completedNCT04163107
What this trial is testing

Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Norwegian University of Science and Technology 19
Not applicableLooking for participantsNCT06404671
What this trial is testing

Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer

Who this might be right for
Ovarian Epithelial Cancer
Alexandria University 250
Not applicableUnknownNCT06349044
What this trial is testing

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Who this might be right for
Her-2 Negative Adenocarcinoma of the Gastro-oesophageal Junction/Gastric AdenocarcinomaHepatocellular CarcinomaBiliary Tract Carcinoma+1 more
Zhejiang Cancer Hospital 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05453500
What this trial is testing

Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
University of Washington 32
Very early researchActive Not RecruitingNCT05634707
What this trial is testing

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

Who this might be right for
Primary Brain TumorBrain Tumor, Recurrent
Duke University 10
Early research (Phase 1)Study completedNCT01065467
What this trial is testing

Panobinostat (LBH589) in Patients With Metastatic Melanoma

Who this might be right for
MelanomaMalignant Melanoma
Dana-Farber Cancer Institute 16
Not applicableUnknownNCT04240600
What this trial is testing

Effect of a Hyperproteic Hyperenergetic Enteral Formula on Body Composition and VEGF in AML During Hospital Stay

Who this might be right for
Acute Myeloid Leukemia, Adult
Hospital General de Mexico 74
Testing effectiveness (Phase 2)WithdrawnNCT00003407
What this trial is testing

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaMyelodysplastic Syndromes+1 more
Rush University Medical Center
Next Page